CAXIX Mutual Fund

NAV$21.24

Fund Essentials - as of Mar 31, 2026

Net Assets
$75M
Expense Ratio
0.97%
Dividend Yield (Current)
6.11%
Holdings
52
Inception Date
Jun 6, 2014
Fund Family
Catalyst Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+8.98%
1 Year+19.06%
3 Year+13.86%
5 Year+8.14%
10 Year+9.27%

Asset Allocation

Stocks: 90.82%
Cash: 2.54%
Other: 6.63%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
GLDMSpdr Gold Minishares Trust (Nyse Arca)4.99%
CVXChevron Corp.4.49%
SNY:PASanofi ADR3.83%
NSRGY:SMNestle S.a. Adr3.70%
TAKTakeda Pharmaceutical Co Ltd3.48%
Top 10 Concentration: 35.22%Report Date: Mar 31, 2026
Download all 52 holdings for CAXIX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
6.11%
Frequency
Annually
Latest Distribution
$0.35
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

CAXIX Mutual Fund Overview

CAXIX Mutual Fund (Catalyst/MAP Global Equity Fund Class I) is managed by Catalyst Funds with $75.4M in net assets. CAXIX expense ratio is 0.97%, holding 52 positions across sectors including Unknown, Health Care, Information Technology. Inception date: 2014-06-06.

CAXIX performance shows a YTD return of 8.98%. The 1-year return is 19.06% and the 5-year return is 8.14%. CAXIX dividend yield stands at 6.11%, paid annually.

CAXIX top holdings include Spdr Gold Minishares Trust (Nyse Arca) (5.0%), Chevron Corp. (4.5%), Sanofi ADR (3.8%), Nestle S.a. Adr (3.7%), Takeda Pharmaceutical Co Ltd (3.5%). View all CAXIX holdings, sector breakdown, or dividend history.

CAXIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. CAXIX alternatives are available via the screener, along with tax-loss harvesting opportunities.